Guild Investment Management, Inc. Abb Vie Inc. Transaction History

Guild Investment Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $4.93 Million - $6.11 Million	-37,322 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$107.43 - $135.93 $205,728 - $260,305	-1,915 Reduced 4.88%	37,322 $5.05 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $592,222 - $672,261	5,566 Added 16.53%	39,237 $4.23 Million
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $189,378 - $210,978	-1,800 Reduced 5.07%	33,671 $3.79 Million
Q1 2021 Apr 19, 2021	BUY	$102.3 - $112.62 $160,713 - $176,926	1,571 Added 4.63%	35,471 $3.84 Million
Q4 2020 Jan 14, 2021	SELL	$80.49 - $108.67 $40,245 - $54,335	-500 Reduced 1.45%	33,900 $3.63 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $176,115 - $206,701	2,050 Added 6.34%	34,400 $3.01 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $2.07 Million - $2.78 Million	-28,270 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $1.82 Million - $2.76 Million	28,270 New	28,270 $2.15 Million

3,846

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Guild Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Guild Investment Management, Inc. with notifications on news.